HIGHLIGHTS
- who: Sophie Goulitquer from the (UNIVERSITY) have published the article: Consequences of blunting the mevalonate pathway in cancer identified by a pluri-omics approach, in the Journal: (JOURNAL)
- what: The authors conducted non-targeted metabolomics and lipidomics analyses by complementary methods and cross-platform initiatives namely mass spectrometry (GC-MS LC-MS) and nuclear magnetic resonance (NMR) to analyze the changes resulting from these treatments.
- how: The LC-MS (Fig 1A B) GC-MS (Fig 1C) and NMR (Fig 1D) raw data were collected and standardized by the amounts of proteins. As each . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.